论文部分内容阅读
人才难留、药械审批环节多、商业保险滞后、税收较高等四大瓶颈“羁绊”外资办医发展脚步。随着国家有关部门出台宏观政策鼓励和引导外资办医,业内人士普遍认为,这些政策将给我国医疗卫生行业带来突破性改变,但是当前存在的人才难留、药械审批环节多、商业保险滞后、税收较高等四大瓶颈“羁绊”外资办医发展脚步,还需进一步出台政策完善相关配套措施。从1997年全国第一家外资医院——北京和睦家医院诞生后,17年来,外资医疗机构并没有成为一支有影响的办医力量,身处其中的投资者、管理者感受到一些制度性障碍仍然存在。此外,国内公立医疗机构过于强大又相对固化的行业格局和运营模式,医患纠纷、医生劳务价值得不到有效体现等问题,也都
Talents are hard to stay, many aspects of the approval of drugstores, commercial insurance lag, higher taxes and other four major bottlenecks “fetters ” With the introduction of macro-policies by state departments to encourage and guide foreign-funded medical treatment, the industry generally believe that these policies will bring about a breakthrough change in China’s medical and health care industry, but the current personnel are hard to stay. Pharmacy approval links and commercial insurance lag Higher taxes and other four major bottlenecks “fetters ” the pace of development of foreign investment in medical treatment, need to further introduce policies to improve the relevant supporting measures. Since 1997, the birthplace of the first foreign-funded hospital in the country, Beijing United Family Hospital, 17 years ago, foreign-funded medical institutions have not become an influential medical force. The investors and managers in these institutions feel some institutional Barriers still exist. In addition, the domestic public medical institutions are too strong and relatively solid industry structure and mode of operation, doctors and patients disputes, doctors can not effectively reflect the value of labor issues, are